A qualitative analysis of the psychedelic mushroom come-up and come-down

The authors conducted a qualitative analysis of self-reported psilocybin (mushroom) experience reports drawn from Erowid.org using three complementary approaches: phenomenological description, thematic content analysis and word frequency analysis. Phenomenological analysis was used to closely read reports and extract first-person quotations that convey the gestalt of the come-up and come-down phases. Thematic content analysis then coded descriptions of the come-up and come-down to determine the relative frequency of emergent themes. Word frequency analysis was used primarily as a quantitative check on whether words associated with identified themes showed different temporal distributions across a larger set of timestamped reports. The dataset for the thematic/phenomenological work comprised reports explicitly describing the come-up (N = 47) and the come-down (N = 83). Word frequency analysis was conducted on a larger set of timestamped mushroom reports (N = 279) to examine temporal patterns across the experience (for example, words used in the first 60 minutes versus later phases). The authors excluded low-dose reports (defined as less than 0.5 grams of dried mushrooms). Reports were authored by people using psilocybin mushrooms outside controlled clinical settings; the sample therefore reflects self-selected, unstructured narratives rather than data collected in trials. Thematic frequency counts were reported as the proportion of reports in which a theme was mentioned. Word frequency analysis examined usage of anxiety-, nausea- and positive-emotion-related words across time bins to test whether the phenomenological themes generalized to the timestamped sample. The authors emphasised that their approach captures the relative prevalence of topics individuals chose to write about rather than providing epidemiological incidence estimates, and they noted features of the dataset that could affect interpretation (for example, unfiltered co-use of cannabis in some reports and potentially non-random attrition in timestamped reports).

The thematic content analysis found a consistent temporal pattern in how people described the psilocybin mushroom experience. For the come-up phase, commonly reported aversive or challenging themes and their reported prevalence in the analysed sample included nausea (34%), anxiety (28%), restlessness (21%), confusion (17%) and detachment (11%). Physical sensations reported during the come-up included energy rushes (19%), tingling (15%), feeling cold (9%), feeling heavy (9%) and clumsiness or uncoordination (9%). By contrast, the come-down phase was more frequently described with positively valenced themes: feeling pleasant (34%), peaceful (22%), reflective (17%), insightful (17%) and socially enjoyable (16%). The authors also noted that a minority of come-down reports referenced racing thoughts, extra excitability or irritability and ideas of dubious value. Word frequency analysis on the larger timestamped sample (N = 279) supported these temporal trends. Words associated with anxiety and nervousness appeared more often in descriptions of the first 60 minutes after ingestion, while words referring to positive emotional states were used more often in later phases. The authors additionally reported increased references to nausea, confusion, laughter, altered breathing and perceptual distortion during earlier phases of the experience. The visualisations and temporal mappings (figures described in the text) were reported to align with plasma psilocin/5-HT2A receptor occupancy and subjective intensity trajectories known from pharmacology, although the extracted text does not reproduce numerical pharmacokinetic comparisons.

The authors interpret their findings as supporting the view that the psilocybin mushroom come-up often resembles an aversive, illness-like or acute stress reaction, whereas the come-down often resembles relief or recovery. They suggest this temporal structure may be therapeutically relevant: an anxiogenic onset and stress-hormone release early in the experience could shape the emotional intensity and memorability of the peak and contribute to later insights or emotional breakthroughs. The authors link this idea to prior suggestions that an acute stress response elicited by psychedelics may be part of the mechanism of therapeutic change, and they note phenomenological parallels with psycholytic psychotherapy traditions that encourage exploration of symbolic material during drug-augmented sessions. The paper also situates the results within broader theoretical proposals that psychedelic-like experiences (hallucinations, spiritual experiences) can be elicited by stress-induced activation of 5-HT2A receptors. The authors reference a model in which transient, stress-related psychotomimetic states may be adaptive and energising, promoting learning and reengagement, while repeated sensitisation could increase risk of psychosis. They further draw parallels between initial anxiogenic effects of psychedelics and early side effects of SSRIs, proposing that initial 5-HT2A activation might be anxiogenic while subsequent downregulation contributes to antidepressant effects. The authors acknowledge multiple limitations. Their focus on psilocybin mushrooms limits generalisability to other classic psychedelics, routes of administration or clinical contexts. Reports came from uncontrolled, self-selected submissions to Erowid, and approximately half of submitted reports are not published on the site, which may bias the sample. Cannabis co-use was common and was not excluded in all reports, which could have potentiated effects. Their exclusion of low-dose reports (<0.5 g) and the unstructured nature of narrative reports mean the analysis cannot provide population-level incidence estimates; it captures only the relative prevalence of themes that authors chose to mention. The authors also raise the possibility of non-random attrition in timestamped reports (for example, that people with more pleasant come-downs might be more likely to continue time-stamping), but report a preliminary review that did not support this concern. Word frequency analyses and visualisations are presented as supportive, secondary evidence rather than the primary basis for conclusions. For future research, the authors recommend hypothesis-driven work in controlled contexts, development of questionnaires and observational methods to quantify the temporal trajectory of come-up and come-down themes, examination of context-dependency (clinical versus recreational settings), investigation of different administration routes and other psychedelic compounds, and theoretical synthesis that integrates their findings with alternative frameworks.

The authors conclude that their qualitative analysis provides initial evidence that the psilocybin mushroom come-up is often experienced as an aversive or stress-like state while the come-down is more often experienced as relief or recovery. They present this study as an important first step in parsing the temporal trajectory of psychedelic experiences and suggest the approach could motivate more formal hypothesis testing and further research into therapeutic mechanisms.